1. Home
  2. SBCF vs SUPN Comparison

SBCF vs SUPN Comparison

Compare SBCF & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seacoast Banking Corporation of Florida

SBCF

Seacoast Banking Corporation of Florida

HOLD

Current Price

$35.57

Market Cap

3.3B

Sector

Finance

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$47.87

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBCF
SUPN
Founded
1926
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.8B
IPO Year
2009
2010

Fundamental Metrics

Financial Performance
Metric
SBCF
SUPN
Price
$35.57
$47.87
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$38.00
$61.60
AVG Volume (30 Days)
1.0M
909.0K
Earning Date
04-28-2026
05-05-2026
Dividend Yield
2.43%
N/A
EPS Growth
10.56
N/A
EPS
0.84
N/A
Revenue
N/A
$392,755,000.00
Revenue This Year
$45.04
$22.70
Revenue Next Year
$6.30
$19.14
P/E Ratio
$42.11
N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.96
$41.76
52 Week High
$35.64
$59.68

Technical Indicators

Market Signals
Indicator
SBCF
SUPN
Relative Strength Index (RSI) 67.00 51.05
Support Level $31.01 $43.27
Resistance Level N/A $47.55
Average True Range (ATR) 0.86 2.50
MACD 0.05 0.08
Stochastic Oscillator 97.87 43.60

Price Performance

Historical Comparison
SBCF
SUPN

About SBCF Seacoast Banking Corporation of Florida

Seacoast Banking Corp of Florida is a holding company. The company provides integrated financial services, including commercial and consumer banking, wealth management, and mortgage and insurance services, to customers across Florida through branch, mobile, and online banking solutions. It maintains day-to-day operations, particularly in the areas of operations, treasury management systems, information technology, and security. The company has one reportable segment that provides these integrated financial services, with segment revenues driven mainly by interest and fees on loans, interest on cash and cash equivalents, and investment securities, and fees on depository products and services.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: